Synergetics (SURG) Gets 510(k) Clearance from FDA for VersaVIT

June 27, 2012 4:06 PM EDT Send to a Friend
Get Alerts SURG Hot Sheet
Trade SURG Now!
Synergetics USA, Inc. (Nasdaq: SURG), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VersaVIT", a novel vitrectomy system for the retinal surgery market.

"The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics' strategy to enter into higher growth areas of retinal surgery," said David M. Hable, President and CEO. "We believe that VersaVIT is a 'game changer' given its functionality, portability and competitive pricing relative to traditional vitrectomy systems." The Company is awaiting CE mark approval, which has been submitted and is currently under review.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Corporate News, FDA

Add Your Comment